These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35837955)

  • 21. Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6.
    Liu Y; Hu M; Fan G; Xing N; Zhang R
    Int Immunopharmacol; 2022 Sep; 110():109044. PubMed ID: 35850052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock.
    Sordi R; Chiazza F; Collotta D; Migliaretti G; Colas RA; Vulliamy P; Brohi K; Dalli J; Collino M; Thiemermann C
    Ann Surg; 2021 May; 273(5):1012-1021. PubMed ID: 31188196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligstroside aglycon, an extra virgin olive oil secoiridoid, prevents inflammation by regulation of MAPKs, JAK/STAT, NF-κB, Nrf2/HO-1, and NLRP3 inflammasome signaling pathways in LPS-stimulated murine peritoneal macrophages.
    Castejón ML; Montoya T; Ortega-Vidal J; Altarejos J; Alarcón-de-la-Lastra C
    Food Funct; 2022 Oct; 13(19):10200-10209. PubMed ID: 36111584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors.
    Hu L; Liu R; Zhang L
    Int Immunopharmacol; 2022 Oct; 111():109095. PubMed ID: 35926270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Synthetic, Host-defense Peptide Protects Against Organ Injury/Dysfunction in a Rat Model of Severe Hemorrhagic Shock.
    Yamada N; Martin LB; Zechendorf E; Purvis GSD; Chiazza F; Varrone B; Collino M; Shepherd J; Heinbockel L; Gutsmann T; Correa W; Brandenburg K; Marx G; Schuerholz T; Brohi K; Thiemermann C
    Ann Surg; 2018 Aug; 268(2):348-356. PubMed ID: 28288070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Inflammatory Response by Crocin Attenuates Hemorrhagic Shock-Induced Organ Damages in Rats.
    Yang L; Dong X
    J Interferon Cytokine Res; 2017 Jul; 37(7):295-302. PubMed ID: 28453369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis.
    Calabrese L; Chiricozzi A; De Simone C; Fossati B; D'Amore A; Peris K
    Expert Opin Drug Metab Toxicol; 2022 May; 18(5):347-355. PubMed ID: 35796377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease.
    Lashgari NA; Roudsari NM; Momtaz S; Sathyapalan T; Abdolghaffari AH; Sahebkar A
    J Neuroimmunol; 2021 Dec; 361():577758. PubMed ID: 34739911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-nitrosocaptopril interrupts adhesion of cancer cells to vascular endothelium by suppressing cell adhesion molecules via inhibition of the NF-кB and JAK/STAT signal pathways in endothelial cells.
    Lian S; Lu Y; Cheng Y; Yu T; Xie X; Liang H; Ye Y; Jia L
    Eur J Pharmacol; 2016 Nov; 791():62-71. PubMed ID: 27565222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
    Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
    Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
    Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock.
    McDonald MC; Mota-Filipe H; Paul A; Cuzzocrea S; Abdelrahman M; Harwood S; Plevin R; Chatterjee PK; Yaqoob MM; Thiemermann C
    FASEB J; 2001 Jan; 15(1):171-186. PubMed ID: 11149905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curculigoside Represses the Proliferation and Metastasis of Osteosarcoma via the JAK/STAT and NF-κB Signaling Pathways.
    Guo H; Zheng L; Guo Y; Han L; Yu J; Lai F
    Biol Pharm Bull; 2022; 45(10):1466-1475. PubMed ID: 36184504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green synthesis of gold nanoparticles using
    Liu Y; Kim S; Kim YJ; Perumalsamy H; Lee S; Hwang E; Yi TH
    Int J Nanomedicine; 2019; 14():2945-2959. PubMed ID: 31114201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of the probiotic cocktail on modulation of the NF-kB and JAK/STAT signaling pathways involved in the inflammatory response in bowel disease model.
    Aghamohammad S; Sepehr A; Miri ST; Najafi S; Rohani M; Pourshafiea MR
    BMC Immunol; 2022 Mar; 23(1):8. PubMed ID: 35240996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats.
    Calbet M; Ramis I; Calama E; Carreño C; Paris S; Maldonado M; Orellana A; Calaf E; Pauta M; De Alba J; Bach J; Miralpeix M
    J Pharmacol Exp Ther; 2019 Aug; 370(2):137-147. PubMed ID: 31085698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-216a protects against human retinal microvascular endothelial cell injury in diabetic retinopathy by suppressing the NOS2/JAK/STAT axis.
    Liu Y; Xiao J; Zhao Y; Zhao C; Yang Q; Du X; Wang X
    Exp Mol Pathol; 2020 Aug; 115():104445. PubMed ID: 32335083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
    Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
    Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway.
    Wang L; Zhao D; Wang H; Wang L; Liu X; Zhang H
    Int Immunopharmacol; 2021 Nov; 100():108117. PubMed ID: 34509933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAK-STAT pathway inhibitors in dermatology.
    Miot HA; Criado PR; de Castro CCS; Ianhez M; Talhari C; Ramos PM
    An Bras Dermatol; 2023; 98(5):656-677. PubMed ID: 37230920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.